Astellas: EC approves PADCEV combination for first-line treatment of advanced urothelial cancer

Posted on August 28, 2024 by Vaseline

KENILWORTH (NJ) (dpa-AFX) – Astellas Pharma Inc. (ALPMY, ALPMY) announced that the European Commission has granted a marketing authorization for Astellas Pharma Inc. (ALPMY, ALPMY) …

Posted in bookmarks

Previous: EC approves PADCEV combination for first-line treatment of advanced urothelial cancer

Next: Huawei Factory AI Chip Launch: Will NVIDIA Become the New Competition? | 28.08.24

bookmarks

Sohn describes mutmaslichen Trump-Attentäter as “großartigen Vater”

Vaseline
September 16, 2024
0

Ryan Wesley R., who drew Trump’s attention, said he had written “a toller type, a nicer guy.” This would have been helped in Ukraine. Mutual […]

bookmarks

Twenty U.S. Foods Drivers Inducted into 2024 International Foodservice Distributors Truck Driver Hall of Fame

Vaseline
August 15, 2024
0

US Foods Holding Corp. (NYSE: USFD) today announced that 20 US Foods drivers have been named to the International Foodservice Distributors Association (IFDA) Truck Driver […]

bookmarks

“In Vitouch’s Amtszeit kam die Universität den Sternen next”

Vaseline
October 22, 2024
0

On 41 years ago, Oliver Vitouch 2012 was busy with the Rektor der Alpen-Adria-Universität, who planned to go to the zurück on October 28 at […]

Related Posts

Sohn describes mutmaslichen Trump-Attentäter as “großartigen Vater”

Twenty U.S. Foods Drivers Inducted into 2024 International Foodservice Distributors Truck Driver Hall of Fame

“In Vitouch’s Amtszeit kam die Universität den Sternen next”